Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to 0.03%.

  • GeneDx Holdings' Return on Capital Employed rose 20.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.06% for FY2024, which is 39.00% up from last year.
  • Per GeneDx Holdings' latest filing, its Return on Capital Employed stood at 0.03% for Q3 2025, which was up 79.81% from 0.01% recorded in Q2 2025.
  • GeneDx Holdings' 5-year Return on Capital Employed high stood at 0.03% for Q3 2025, and its period low was -3.39% during Q2 2021.
  • For the 3-year period, GeneDx Holdings' Return on Capital Employed averaged around -0.50%, with its median value being -0.29% (2024).
  • As far as peak fluctuations go, GeneDx Holdings' Return on Capital Employed skyrocketed by 252bps in 2022, and later tumbled by 82bps in 2023.
  • GeneDx Holdings' Return on Capital Employed (Quarterly) stood at -0.93% in 2021, then slumped by 36bps to -1.29% in 2022, then surged by 79bps to -0.50% in 2023, then soared by 44bps to -0.06% in 2024, then climbed by 20bps to 0.03% in 2025.
  • Its Return on Capital Employed was 0.03% in Q3 2025, compared to 0.01% in Q2 2025 and -0.04% in Q1 2025.